Merck launches GMP-compliant cell culture media line in China
The new line, representing an investment of nearly €6.6m ($7.1m), is located at the Life Science Center in Nantong. This development is aimed at meeting the increasing local
Apollo Therapeutics has entered into a collaboration with the University of Oxford in the UK to propel drug discovery and development.
The funding will support ongoing clinical trials for X-Linked Retinitis Pigmentosa (XLRP) and advance the company’s Dry Age-related Macular Degeneration (dAMD) programme. The investment round included contributions from